New Study in Ewing Sarcoma Open to Enrollment

New Study in Ewing Sarcoma Open to Enrollment

SARC037 is a phase I study protocol to determine the recommended dose of trabectedin given as a 1-hour infusion in combination with low dose irinotecan. All patients enrolled will receive trabectedin combination …

Read more
Open Accruing SARC Studies

Open Accruing SARC Studies

Open accruing studies for you to refer or enroll your patients: SARC024 for Rhabdomyosarcoma (alveolar and embryonal) and Mesenchymal Chondrosarcoma  SARC031 for Unresectable or Metastatic NF1 Associated or Sporadic Malignant Peripheral Nerve …

Read more